Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Calidi Biotherapeutics, Inc. | StockGist | StockGist

Companies
CLDI
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CLDISCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Calidi Biotherapeutics, Inc.

Filed Feb 10, 2026

Accepted Feb 10, 2026, 12:00 AM ET

CIK 0001855485

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Calidi Biotherapeutics, Inc.

Person Type

OO

CUSIP: 320703408

Amendment History

3 filings

SCHEDULE 13G
Original
Feb 4, 20260002109116-26-000002
SCHEDULE 13G/A
Amendment 1
Aug 14, 20250001172661-25-003581
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Feb 10, 20260001493152-26-005942

Recent Filings

Calidi Biotherapeutics, Inc.3 days ago

Calidi Biotherapeutics, Inc.1 weeks ago

Calidi Biotherapeutics, Inc.3 weeks ago

Calidi Biotherapeutics, Inc.1 months ago

Calidi Biotherapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice